Additionally, TCGA data (http://gepia.cancer-pku.cn/) showed that LPCAT2 expression level was positively correlated with overall survival in CRC patients (Fig. 1H), and LPCAT2 expression was not associated with the mutation of TP53 (Supplementary Fig. 1H). This evidence concerns the gene LPCAT2 and colorectal carcinoma.